Strategies to Prevent or Remediate Cancer and Treatment-Related Aging.
Journal
Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
received:
13
02
2020
revised:
20
03
2020
accepted:
17
04
2020
pubmed:
30
4
2020
medline:
22
6
2021
entrez:
30
4
2020
Statut:
ppublish
Résumé
Up to 85% of adult cancer survivors and 99% of adult survivors of childhood cancer live with an accumulation of chronic conditions, frailty, and/or cognitive impairments resulting from cancer and its treatment. Thus, survivors often show an accelerated development of multiple geriatric syndromes and need therapeutic interventions. To advance progress in this area, the National Cancer Institute convened the second of 2 think tanks under the auspices of the Cancer and Accelerated Aging: Advancing Research for Healthy Survivors initiative. Experts assembled to share evidence of promising strategies to prevent, slow, or reverse the aging consequences of cancer and its treatment. The meeting identified research and resource needs, including geroscience-guided clinical trials; comprehensive assessments of functional, cognitive, and psychosocial vulnerabilities to assess and predict age-related outcomes; preclinical and clinical research to determine the optimal dosing for behavioral (eg, diet, exercise) and pharmacologic (eg, senolytic) therapies; health-care delivery research to evaluate the efficacy of integrated cancer care delivery models; optimization of intervention implementation, delivery, and uptake; and patient and provider education on cancer and treatment-related late and long-term adverse effects. Addressing these needs will expand knowledge of aging-related consequences of cancer and cancer treatment and inform strategies to promote healthy aging of cancer survivors.
Identifiants
pubmed: 32348501
pii: 5827003
doi: 10.1093/jnci/djaa060
pmc: PMC7850536
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
112-122Subventions
Organisme : NIA NIH HHS
ID : U01 AG057545
Pays : United States
Organisme : NCI NIH HHS
ID : DP2 CA195765
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG013925
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA132378
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001855
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG020480
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA137788
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG053198
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG056589
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG059206
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA172119
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218496
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA218732
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG020487
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG020478
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG062413
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021334
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG052964
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG059206
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA129769
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA231014
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG056278
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG061456
Pays : United States
Informations de copyright
Published by Oxford University Press 2020.